EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of the COVID-19 pandemic on antibiotic utilization in a tertiary hospital

Burcu Çalişkan Demirkiran, Hanefi C Gül, Hakan Erdem

The Journal of Infection in Developing Countries · 2024

DOI: 10.3855/jidc.18897 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2024. Verfasst von Burcu Çalişkan Demirkiran und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Dr Abdurrahman Yurtaslan Ankara Training and Research Hospital, University of Health Sci…. Hauptthemen laut MEDLINE: Tertiary Care Centers, Anti-Bacterial Agents, COVID-19. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This study aimed to determine the use of antimicrobial drugs during the second year of the coronavirus disease 2019 (COVID-19) pandemic, and evaluate the pandemic`s impact on antibiotic use by comparing with the pre-pandemic period. Methodology: The study was a retrospective point prevalence study. Patients aged ≥ 18 years, who received antibiotics in our hospital between 11 February 2020. and 3 January 2022 were evaluated. The antibiotics were categorized according to the 2021 Access/Watch/Reserve (AWARe) classification. Compliance with recommendations from infectious diseases (ID) physicians, and reasons for inappropriate treatment were evaluated.

Results

Among the hospitalized patients, 323 (36.4%) during the pre-pandemic days (PPD), and 361 (50.1%) during pandemic days (PD), used at least one antimicrobial drug (p < 0.001). The most frequently used antibiotics during PPD and PD were piperacillin, tazobactam, and imipenem/meropenem. The use of the "Access" group antibiotics decreased in the PD, while the use of the "Watch" and "Reserve" groups increased (p = 0.034). There was 100% (n = 209) compliance with ID consultation in the PPD, and 91.9% (n = 227) in the PD (p < 0.001). In the PPD, 64 (19.8%). of the treatments received by inpatients were inappropriate, and during the PD 100 (27.7%) were inappropriate (p = 0.016).

Conclusions

The pandemic led to an increase in the overuse and inappropriate use of antimicrobial drugs, particularly in the Watch and Reserve groups, in both COVID-19 and non-COVID-19 clinics. There was a notable transition towards the increased utilization of broad-spectrum antibiotics during the pandemic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tertiary Care CentersAnti-Bacterial AgentsCOVID-19HumansRetrospective StudiesMaleFemaleMiddle AgedAgedAdultSARS-CoV-2Drug UtilizationAntimicrobial StewardshipAged, 80 and overPandemics

Stichwörter der Autor:innen

COVID-19antibioticsinappropriate drug usepandemic

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Infectious Diseases and Clinical Microbiology, Dr Abdurrahman Yurtaslan Ankara Training and Research Hospital, University of Health Sciences, Ankara, Türkiye.
  • Department of Infectious Diseases and Clinical Microbiology, Gülhane Training and Research Hospital, University of Health Sciences, Ankara, Türkiye.

Zitieren

APA

Çalişkan Demirkiran, B., Gül, H. C., & Erdem, H. (2024). Impact of the COVID-19 pandemic on antibiotic utilization in a tertiary hospital. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.18897

Vancouver

Çalişkan Demirkiran B, Gül HC, Erdem H. Impact of the COVID-19 pandemic on antibiotic utilization in a tertiary hospital. The Journal of Infection in Developing Countries. 2024. doi:10.3855/jidc.18897

BibTeX
@article{alikanDemirkiran2024,
  author = {Çalişkan Demirkiran, Burcu and Gül, Hanefi C and Erdem, Hakan},
  title = {Impact of the COVID-19 pandemic on antibiotic utilization in a tertiary hospital},
  journal = {The Journal of Infection in Developing Countries},
  year = {2024},
  doi = {10.3855/jidc.18897}
}
Kostenlos starten →